BEMFOLA 225 IU/0.375 ml, solution for injection in a pre-filled pen pen, 0.375 ml
Active ingredients: Follitropin alpha
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 0.375 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BEMFOLA 225 UI/0,375 ml, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche(s) en verre de 0,375 ml dans stylo pré-rempli avec 1 aiguille(s) avec1 tampon(s) alcoolisé(s)
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 May 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67933658CIP72793921CIP133400927939211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOLLITROPINE ALFAsolution | 225 UI · 0,375 ml de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.